MTOR and hepatocellular carcinoma: Given such distinctive characteristics in HCC, we hypothesized that somatic genetic alterations may affect PI3K/AKT/mTOR pathway and we identified a mutation - S1113R on the inositol polyphosphate 4-phosphatase (IP4P) domain.